Global High Throughput Screening (HTS) Market 2024-2028
The high throughput screening (HTS) market is forecasted to grow by USD 19.9 bn during 2023-2028, accelerating at a CAGR of 12.12% during the forecast period. The report on the high throughput screening (HTS) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in R and D investments, increasing prevalence of chronic diseases, and patent expiration of drugs.
Technavio's high throughput screening (HTS) market is segmented as below:
- Target identification and validation
- Primary and secondary screening
- Toxicology assessment
- Stem cell research
- Pharmaceutical and biotechnology companies
- Academic and research institutes
By Geographical Landscape
- North America
- Rest of World (ROW)
This study identifies the increasing focus on promotional activities as one of the prime reasons driving the high throughput screening (HTS) market growth during the next few years. Also, growth in outsourcing activities and technological advances in the high throughput screening services will lead to sizable demand in the market.
The report on the high throughput screening (HTS) market covers the following areas:
- High throughput screening (HTS) market sizing
- High throughput screening (HTS) market forecast
- High throughput screening (HTS) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading high throughput screening (HTS) market vendors that include Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the high throughput screening (HTS) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.